GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (FRA:QS50) » Definitions » 5-Year RORE %

Straumann Holding AG (FRA:QS50) 5-Year RORE % : 19.42% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Straumann Holding AG 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Straumann Holding AG's 5-Year RORE % for the quarter that ended in Jun. 2024 was 19.42%.

The industry rank for Straumann Holding AG's 5-Year RORE % or its related term are showing as below:

FRA:QS50's 5-Year RORE % is ranked better than
77.2% of 671 companies
in the Medical Devices & Instruments industry
Industry Median: -4.02 vs FRA:QS50: 19.42

Straumann Holding AG 5-Year RORE % Historical Data

The historical data trend for Straumann Holding AG's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Straumann Holding AG 5-Year RORE % Chart

Straumann Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.15 -12.20 9.73 14.46 -2.02

Straumann Holding AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.11 14.46 9.70 -2.02 19.42

Competitive Comparison of Straumann Holding AG's 5-Year RORE %

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Straumann Holding AG's 5-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's 5-Year RORE % falls into.



Straumann Holding AG 5-Year RORE % Calculation

Straumann Holding AG's 5-Year RORE % for the quarter that ended in Jun. 2024 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( 0.177-0.037 )/( 0.957-0.236 )
=0.14/0.721
=19.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2024 and 5-year before.


Straumann Holding AG  (FRA:QS50) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Straumann Holding AG 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Straumann Holding AG's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Straumann Holding AG Business Description

Address
Peter Merian-Weg 12, Basel, CHE, 4002
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly one third of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

Straumann Holding AG Headlines

No Headlines